Our long term goal is to understand the regulatory mechanisms of carbohydrate metabolism in various mammalian tissues. Specifically, we are interested in the regulation of phosphofructokinase, one of the key regulatory enzymes of glycolysis. In 1980, we and two other groups discovered the most potent activator of phosphofructokinase, fructose 2,6-P2, in liver. Subsequently, this activator is found to occur in all mammalian tissues, in plants, and yeast and thus stimulated a new investigation into the roles of fructose 2,6-P2 in regulation of glycolysis in these cells. It plays an important role in dietary and hormonal regulation of glucose homeostasis in liver. It also is important in stimulation of glycolysis in working heart and under epinephrine and insulin stimulation. Our current objective is to determine its role in liver under ischemic conditions, since we found that the fructose 2,6-P2 level change within a few seconds and continue to oscillate for 2 min. We continue to investigate the biochemical mechanism for this interesting observation. We are also investigating the structure and function of various Fru 6-P,2-kinase:Fru 2,6-Pase isozymes which catalyze the synthesis and degradation of Fru 2,6-P2. These studies will help in our understanding of how carbohydrate metabolism is regulated in various mammalian tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK016194-23
Application #
2136994
Study Section
Biochemistry Study Section (BIO)
Project Start
1977-08-01
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
23
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Jin, Eunsook S; Sherry, A Dean; Malloy, Craig R (2009) Evidence for reverse flux through pyruvate kinase in skeletal muscle. Am J Physiol Endocrinol Metab 296:E748-57
van Zijl, Peter C M; Jones, Craig K; Ren, Jimin et al. (2007) MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 104:4359-64
Jin, Eunsook S; Park, Byung-Hyun; Sherry, A Dean et al. (2007) Role of excess glycogenolysis in fasting hyperglycemia among pre-diabetic and diabetic Zucker (fa/fa) rats. Diabetes 56:777-85
Jin, Eunsook S; Jones, John G; Burgess, Shawn C et al. (2005) Comparison of [3,4-13C2]glucose to [6,6-2H2]glucose as a tracer for glucose turnover by nuclear magnetic resonance. Magn Reson Med 53:1479-83
Jin, Eunsook S; Jones, John G; Merritt, Matthew et al. (2004) Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative. Anal Biochem 327:149-55
Jin, Eunsook S; Uyeda, Kosaku; Kawaguchi, Takumi et al. (2003) Increased hepatic fructose 2,6-bisphosphate after an oral glucose load does not affect gluconeogenesis. J Biol Chem 278:28427-33
Lee, Yong-Hwan; Li, Yang; Uyeda, Kosaku et al. (2003) Tissue-specific structure/function differentiation of the liver isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Biol Chem 278:523-30
Kawaguchi, T; Veech, R L; Uyeda, K (2001) Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2,6-bisphosphate and ribose 1,5-bisphosphate. J Biol Chem 276:28554-61
Sakurai, M; Cook, P F; Haseman, C A et al. (2000) Glutamate 325 is a general acid-base catalyst in the reaction catalyzed by fructose-2,6-bisphosphatase. Biochemistry 39:16238-43
Wu, R F; Uyeda, K (1999) Mutations in the charged residues of the amino terminus of rat liver fructose 6-phosphate,2-kinase:Fructose 2,6-bisphosphatase: effects on regulation. Arch Biochem Biophys 371:15-23

Showing the most recent 10 out of 36 publications